Last updated on: 16/05/2013
Name of organisation
1) Department/Research groupKappa Santé
2) Organisation/affiliationKappa Santé
Short Name in the inventoryKappa Santé
Administrative Contact
Title Mrs
Last name Texier
First name Nathalie
Address line 14 rue de Cléry
Address line 2
Address line 3
CityParis
Postcode75002
CountryFrance
Phone number (incl. country code)0033144827473
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name SCHÜCK
First name Stéphane
Address line 14 rue de Cléry
Address line 2
Address line 3
CityParis
Postcode75002
CountryFrance
Phone number (incl. country code)0033144827474
Alternative phone number
Fax number (incl. country code)
Alternative Scientific Contact
Title Miss
Last name LEPROUST
First name Sandy
Address line 14 rue de Cléry
Address line 2
Address line 3
CityParis
Postcode75002
CountryFrance
Phone number (incl. country code)0033144825015
Alternative phone number
Fax number (incl. country code)
2. Description
Kappa Santé is a CRO specialising in epidemiology, clinical research and public health interventions.
Kappa Santé offers proven expertise both on a national and international level. Its diverse integrated know-how guarantees expert project management, from the concept through to publication.
From its creation at the end of 2002, Kappa Santé has relied on the human factor in building a high-performance, multitalented, united team. Quality system development has also been one of our priorities in order to achieve the highest level of quality in our service offer, at each stage of the projects that we manage.
Kappa Santé's activities focus on epidemiology and clinical research, constantly integrating applications arising from NICT.
3. Category
For profit organisation
4. Available resources
In houseVia Contacts/Network
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Disorders of the central nervous system
Ear, nose and oropharynx disorders
Endocrine disorders
Eye disorders
Gastrointestinal tract
Geriatrics
Gynaecology
Immunological products and vaccines
Immunosuppression
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Nutrition and blood
Paediatrics
Pregnancy
Psychiatry
Renal impairment
Respiratory diseases
Skin disorders
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Drug Utilisation
Interventional Clinical Trial
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 150 and 1499
Greater than 15000
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
No
Electronic data capture systems
Yes
System used:
own system
Interactive voice response systems
No
Call centre
Yes
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
THALES/CEGEDIM5
CALLIOPE4
11. Registries established by centre
Disease RegistryAlzheimer Disease
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
None
14. Interest in research opportunities which are funded
By pharmaceutical companies
By charities
By government
By research councils
By EU funding schemes
15. Interest in contract research only if free to publish results
No
16. Selected publications of the last 5 calendar years
ReferenceLink to web-publication
Dupont S, Verny M, Harston S, Cartz-Piver L, Schück S, Martin J, Puisieux F,
Alecu C, Vespignani H, Marchal C, Derambure P. Seizures in the elderly:
development and validation of a diagnostic algorithm. Epilepsy Res. 2010
May;89(2-3):339-48. Epub 2010 Mar 15
Crochard A, El Hasnaoui A, Pouchain D, Huas D, Arnulf I, Krieger J, Lainey E,
Le Jeunne P, Leger D, Schuck S, Texier N, Tison F, Montplaisir J. Diagnostic
indicators of restless legs syndrome in primary care consultations: the DESYR
study. Mov Disord. 2007 Apr 30;22(6):791-7
Allain H, Schück S, Nachit-Ouinekh F, Plouin P, Brunon AM, Boulliat J, Mercier
F, Slama A, Baulac M, El Hasnaoui A. Improvement in quality of life after
initiation of lamotrigine therapy in patients with epilepsy in a naturalistic
treatment setting. Seizure. 2007 Mar;16(2):173-84. Epub 2007 Jan 8
Robert PH, Schuck S, Dubois B, Olié JP, Lépine JP, Gallarda T, Goni S, Troy S;
Investigators' Group. Screening for Alzheimer's disease with the short cognitive
evaluation battery. Dement Geriatr Cogn Disord. 2003;15(2):92-8
Lanteri-Minet M, Allain H, Nachit-Ouinekh F, Bentue-Ferrer D, Gilbert P, Schück S, El Hasnaoui A; Comite d'Orientation National. NOEMIE: an epidemiological study of migraine at work: results from 17 occupational health centres.
Rev Neurol 2004; 160(10):928-34
